Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

AdvanSix Inc. (ASIX) Form 8-K — Aug 7, 2026

$ASIXForm 8-KItems 2.02, 8.01, 9.01Filed Aug 7, 2026, 6:29 AM ET0001673985-26-000045Original filing

AdvanSix reported second quarter 2026 results on August 7, 2026, with sales of $421 million, up 3% year over year, but diluted EPS of just $0.12, down 90% from $1.15 a year ago. Adjusted EPS of $0.19 fell 85% and Adjusted EBITDA of $31.9 million declined 43% versus the prior-year quarter. The profit collapse was driven primarily by a 15% sales volume decline, led by ammonium sulfate weakness in Plant Nutrients as poor farmer economics cut in-season fertilizer purchases, with 18% favorable pricing only partially offsetting the shortfall. First-half 2026 swung to a net loss of $12.3 million with negative free cash flow of $61.9 million.

Key figures

Eps
0.12
Revenue
421284000
Guidance
2026 capital expenditures of $75-95 million (vs $116 million in 2025); plant turnaround pre-tax income impact of approximately $17 million in 2026 (vs ~$25 million in 2025); expects 2H 2026 sequential cash flow improvement from lower CapEx, working capital tailwinds, 4Q 2026 Plant Nutrients pre-buy, and cash tax optimization
Net Income
3248000
Revenue Yoy
3%
Total Assets
1673016000
Cash Position
7217000
Shares Outstanding
27001186
Capex q2
20714000
Volume change
-15%
Pricing change
18% favorable
Adjusted ebitda
31888000
Dividend per share
0.16
Adjusted diluted eps
0.19
Adjusted ebitda margin
7.6%
Line of credit long term
275000000
Cash flow from operations q2
10038000
Plant nutrients sales change
-16%
Adjusted diluted eps prior year
1.24

Price after filing

1 day: -17.7%7 days: -14.9%30 days: -12.9%

Close on the filing date to close N calendar days later (from $20.03). Historical, not a forecast.

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.